LSB Industries Inc. (NYSE:LXU) shares moved up 3.51% in last trading session and ended the day at $7.38. LXU Gross Margin is 17.00% and its has a return on assets of -2.30%. LSB Industries Inc. (NYSE:LXU) quarterly performance is -52.26%.
LSB Industries, Inc. (NYSE: LXU) announced that its Board of Directors has appointed Interim Chief Executive Officer Daniel D. Greenwell as President and Chief Executive Officer, effective immediately. Mr. Greenwell has served as Interim Chief Executive Officer since September 2015.
Ambac Financial Group, Inc. (NASDAQ:AMBC) ended the last trading day at $14.97. Company weekly volatility is calculated as 3.87% and price to cash ratio as 24.87. Ambac Financial Group, Inc. (NASDAQ:AMBC) showed a weekly performance of 3.46%.
Ambac Financial Group, Inc. (NASDAQ: AMBC) announced that Ambac Assurance and Financial Guaranty Insurance Company have issued a letter to the Governor and other top officials of Puerto Rico, regarding the Commonwealth’s illegal clawback of revenues pledged to the Puerto Rico Infrastructure Financing Authority (“PRIFA”).
On 29 December, Anavex Life Sciences Corp. (NASDAQ:AVXL) shares decreased -10.67% and was closed at $6.28. AVXL EPS growth in last 5 year was -0.90%. Anavex Life Sciences Corp. (NASDAQ:AVXL) year to date (YTD) performance is -33.54%.
Anavex Life Sciences (NASDAQ: AVXL) is under heavy pressure early after disclosing an SEC subpoena and formal investigation in its 10-K. The company believes the subpoena and investigation relate to the recent unusual activity in the market for the Company’s shares.
Weight Watchers International, Inc. (NYSE:WTW) shares advanced 6.96% in last trading session and ended the day at $19.37. WTW Gross Margin is 50.30% and its has a return on assets of 3.40%. Weight Watchers International, Inc. (NYSE:WTW) quarterly performance is 208.44%.
Vetr upgraded shares of Weight Watchers International, Inc. (NYSE:WTW) from a sell rating to a hold rating in a research note published on Monday, Analyst Ratings Net reports. The firm currently has $21.68 price target on the stock.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) caters to the Healthcare space. Its weekly performance is -6.83%. On the last day of trading company shares ended up at $9.55. Ocular Therapeutix, Inc. (NASDAQ:OCUL) distance from 50-day simple moving average (SMA50) is -0.06%.
Ocular Therapeutix™, Inc. (NASDAQ:OCUL), announced topline results from a Phase 2 exploratory clinical trial designed to evaluate a range of objective and subjective measures (signs and symptoms, respectively) for DEXTENZA™ (sustained release dexamethasone) Intracanalicular Depot for the treatment of inflammatory dry eye disease. This trial was intended to explore which measures would be appropriate to include in the design of a future clinical trial to evaluate efficacy of DEXTENZA or other molecules in a sustained release product as a potential therapy for dry eye disease.